4-Aminoquinoline
Structural formula of 4-aminoquinoline
Space-filling model of the 4-aminoquinoline molecule
Names
Preferred IUPAC name
Quinolin-4-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.167.771
UNII
  • InChI=1S/C9H8N2/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H2,10,11) checkY
    Key: FQYRLEXKXQRZDH-UHFFFAOYSA-N checkY
  • n1ccc(c2ccccc12)N
Properties
C9H8N2
Molar mass 144.177 g·mol−1
Appearance Powder to crystalline, White/Yellow/Orange
Melting point 151.0 to 155.0 °C
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
 Causes skin and serious eye irritation
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. The compound has been used as a precursor for the synthesis of its derivatives.[1]

A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections.[2] Examples include amodiaquine, chloroquine, and hydroxychloroquine.[3] Other uses for the derivatives are: anti-asthmatic, antibacterial, anti-fungal, anti-malarial, antiviral and anti-inflammatory agents. [1]

A patent application for 4-aminoquinoline compounds was filed in 2002 and published in 2005.[4]

See also

References

  1. 1 2 Al-Ahmary KM, Alenezi MS, Habeeb MM (2016-08-01). "Synthesis, spectroscopic and DFT theoretical studies on the hydrogen bonded charge transfer complex of 4-aminoquinoline with chloranilic acid". Journal of Molecular Liquids. 220: 166–182. doi:10.1016/j.molliq.2016.04.074. ISSN 0167-7322.
  2. ↑ Bosak A, Opsenica DM, Šinko G, Zlatar M, Kovarik Z (2019-08-01). "Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase". Chemico-Biological Interactions. 308: 101–109. doi:10.1016/j.cbi.2019.05.024. ISSN 0009-2797. PMID 31100281. S2CID 157067252.
  3. ↑ Bray PG, Hawley SR, Ward SA (1996). "4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake". Mol. Pharmacol. 50 (6): 1551–8. PMID 8967977.
  4. ↑ DeVita R, Chang L (13 January 2005). "4-Aminoquinoline Compounds" (PDF). United States Patent Application Publication.
  • Bourne SA, De Villiers K, Egan TJ (2006). "Three 4-aminoquinolines of antimalarial interest". Acta Crystallogr C. 62 (Pt 2): o53–7. doi:10.1107/S0108270105041235. PMID 16456284.
  • "4-Aminoquinoline 578-68-7 | TCI America". www.tcichemicals.com. Retrieved 2020-03-06.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.